Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?
Align Technology is undervalued with a P/FCF multiple of 15x and WACC of 11.55%, despite strong market share and margin improvements. ALGN's Invisalign dominates over 90% of the clear aligners market, supported by high switching costs and premium pricing power. Financials show solid adjusted EBIT margins at 21.8%, with adjusted EPS on an upward trend, despite pandemic-related sales growth stagnation.
Align Technology adds restorative capabilities to the iTero Lumina Solutions - the iTero Lumina intraoral scanner and the iTero Lumina Pro dental imaging system.
US stocks had a great 2024 but there still were names last year that failed to capitalise on the positive sentiment. A handful of them, however, are fairly positioned for a comeback this year, according to analysts at Jefferies.
Align Technology commercially launches its Invisalign Palatal Expander System in Turkey after approval from TMMDA.
Align Technology reports fourth-quarter 2024 revenue growth. This can be mostly attributed to the robust performance of the Imaging Systems & CAD/CAM Services business segment.
Align Technology (ALGN 0.75%), known for its Invisalign clear aligners and digital dental systems, announced its fourth-quarter 2024 results on Feb. 5, 2025. The earnings release highlighted stable performance amid currency and demand challenges.
Although the revenue and EPS for Align Technology (ALGN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Align Technology (ALGN) came out with quarterly earnings of $2.44 per share, beating the Zacks Consensus Estimate of $2.43 per share. This compares to earnings of $2.42 per share a year ago.
Align Technology, Inc. (NASDAQ:ALGN ) Q4 2024 Earnings Conference Call February 5, 2025 4:30 PM ET Company Participants Shirley Stacy - Vice President, Corporate Communications & Investor Relations Joe Hogan - President & Chief Executive Officer John Morici - Chief Financial Officer Conference Call Participants Michael Cherny - Leerink Partners Elizabeth Anderson - Evercore ISI Glen Santangelo - Jefferies Jon Block - Stifel David Saxon - Needham Jeff Johnson - Baird Brandon Vazquez - William Blair Jason Bednar - Piper Sandler Steven Valiquette - Mizuho Michael Ryskin - Bank of America Erin Wright - Morgan Stanley Operator Greetings. Welcome to the Align Fourth Quarter and Full Year 2024 Earnings Call.
Align Technology forecast its first-quarter revenue below analysts' estimates on Wednesday, signaling soft demand for its clear teeth aligners from teenagers and younger patients.
Here is a sneak peek into how five MedTech stocks, BSX, HOLX, TECH, STE and ALGN, are expected to fare in their quarterly results, slated to be released tomorrow.